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1. INTRODUCTION 
Acetylcholinesterase (ACHE) is a tightly mem- 
brane-bound enzyme in the mammalian system 
and the most commonly used agent for solubilizing 
this enzyme is Triton X-100. We have indicated 
that a serotonin-sensitive arylacylamidase (AAA) 
is identical with AChE in different mammalian 
sources [ 1-3]. 
Phosphatidylinositol (PI)-specific phospholip- 
ase C has found widespread use in the solubiliza- 
tion of membrane-bound enzymes [4-6]. More- 
over, sodium deoxycholate (DOC) activated the 
endogenous PI-specific phospholipase C in the 
brain and platelets [7-9]. Here we show that PI- 
specific phospholipase C of S. aureus or DOC-acti- 
vated endogenous phospholipase C solubilizes 
AChE and AAA of sheep brain basal ganglia and 
that beyond a critical [DOC], a loss in activity of 
these enzymes occurs which can be restored by ex- 
ternally added PI. 
2. MATERIALS AND METHODS 
2.1. Materials 
PI (soybean), phosphatidylcholine dimyristoyl 
and dipalmitoyl (PC), phosphatidylserine (PS), 
phosphatidylethanolamine (PE), phospholipase A2 
(Naja naja), phospholipase C (Bacillus cereus) and 
DOC were obtained from Sigma Chemicals (St 
Louis MO). Concanavalin A (con A)-Sepharose 
was prepared as in [10]. Basal ganglia isolated 
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from sheep brain was kept frozen at -20°C until 
used. PI-speciflc phospholipase C from Staphylo- 
coccus aureus (Cowan strain) was cultured and pu- 
rified by Amberlite CG-50 column chromatog- 
raphy as in [11]. The peak fraction of phospho- 
lipase C eluted from the column was dialyzed 
against 50 vol. distilled water (6 h) before use. 
Phospholipids were used as sonicated suspensions 
in water. 
2.2. Solubilizatibn experiments 
A 10% homogenate of basal ganglia in 50 mM 
Hepes (N-2 hydroxyethyl piperazine-N'-2-ethane- 
sulphonic acid)/NaOH buffer (pH 7.4) was pre- 
pared (9 mg protein/ml). This homogenate was 
subjected to solubilization by two methods: 
(i) By adding 0.3 ml S. aureus phospholipase C 
(20 units); or 
(ii) By adding DOC at different concentrations, to
0.2 ml homogenate in final 0.6 ml vol.in 30 mM 
Hepes/NaOH buffer (pH 7.4). 
The above mixture was incubated for 30-40 min 
at 37°C with shaking. After cooling the mixture in 
ice, it was centrifuged at 105 000 x g for 60 min 
and the supernatant was considered as the sol- 
ubilized portion. 
2.3. ConA-Sepharose column chromatography 
This was done on a 4 x 1 cm column using 2 -  
3 ml solubilized enzyme. The column was washed 
with 100 ml 0.5 M NaC1/20 mM Tris-HCl buffer 
(pH 7.4) and eluted with 1 M a-methylglucoside/ 
20 mM Tris-HCl buffer (pH 7.4). The eluted en- 
zyme was dialyzed against 20 mM Tris--HC1 
buffer (pH 7.4). 
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2.4. Enzyme assays 
ACHE, AAA and alkaline phosphatase were as- 
sayed as in [3,12,13]. Phospholipase C activity was 
assayed as in [11] using 1 mg PI in the incubation 
mixture and one unit of activity was defined as 
0.01 ~tmol water-soluble organic phosphorus re- 
leased in 90 min at 37°C. 
3. RESULTS 
3.1. Solubilization by S. aureus phospholipase C 
Under the conditions of solubilization described, 
PI-specific phospholipase C solubilized -60% of 
both AChE and AAA from basal ganglia. Use of 
higher units of phospholipase C (up to 26 units) or 
longer incubation periods (up to 60 min) did not 
result in anything > 65% solubilization. There was 
no loss of enzyme activities as the insolubilized ac- 
tivity was fully recovered in the 105 000 x g sedi- 
Table 1 
Solubilization of AChE and AAA from sheep basal 
ganglia by S. aureus phospholipase C 
Addition 
% Activity released into 
105 000 x g supernatant 
Ache AAA 
No addition 9 10 
Phospholipase C 61 60 
+ 2 mM CaCI2 61 60 
+ 10 mM CaCI2 36 39 
+ 0.2 M KC1 32 32 
+ 100/~M PMSF 60 60 
+ 1 mg PI 48 47 
+ 2 mg PI 25 26 
+ 4 mg PI 15 16 
+ 1 mg PC 57 56 
+ 4 mg PC 49 48 
Sheep basal ganglia homogenate in 50 mM Hepes/ 
NaOH buffer (pH 7.4) was incubated as in section 2 
with the additions hown, for 40 min at 37°C then cen- 
trifuged at 105 000 x g for 60 min. Phospholipase C used 
was 20 units. The supernatant was assayed for AChE 
and AAA. Values are expressed as % of the activity of an 
unincubated control homogenate. (There was no detec- 
table loss of enzyme activity when the homogenate was 
incubated at 37°C for 40 min.) CaC12, KC1, PMSF, PI or 
PC alone at the concentrations u ed did not affect AChE 
or AAA activity or their solubilization as observed in 
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Fig.1. % activity of AChE (-e-) and AAA (-o-) in the 
105 000 x g supernatant and 105 000 x g residue of basal 
ganglia homogenate after DOC treatment. The homoge- 
nate was incubated with DOC at various concentrations 
as in section 2. After incubation at 37°C for 30 min, it 
was centrifuged at 105 000xg for 60 min. AChE and 
AAA activity in the supernatant and residue (suspended 
in 50 mM Hepes/NaOH) buffer (pH 7.4) was estimated. 
Activity is expressed as % of incubated control sample of 
homogenate: (---) activity in the residue; ( - - )  activity 
in the supernatant. 
ment. Only those fractions from the Amberlite 
CG-50 column which had phospholipase C activity 
were able to solubilize the enzymes. Several ines 
of evidence indicated that the solubilization was 
brought about by a PI-specific phospholipase C 
(table 1). Thus 0.2 M KC1 a known inhibitor of 
bacterial phospholipase C(5) reduced the solubil- 
ization. Although 2 mM CaC12 did not affect, 
10 mM CaC12 suppressed solubilization. Addition 
of 100 ~tM phenyl-methyl-sulphonyl fluoride 
(PMSF) an inhibitor of serine protease did not in- 
hibit solubilization. More convincing evidence 
came from the fact that PI at different concentra- 
tions (used as competitive inhibitor) was able to 
prevent solubilization to a different extent while 
PC was inadequate to do so. Use of B. cereus PC- 
specific phospholipase C or phospholipase A2 
(up to 100 units) resulted in ~< 10% solubilization 
over the controls. There was no inactivation of 
AChE and AAA by these phospholipases. 
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3.2. Use of DOC for solubilization 
The use of different concentrations of DOC for 
solubilizing AChE and AAA is shown in fig.1. 
While the maximum solubilization (60%) in the 
105 000 x g supernatant was observed at 3 mM 
DOC, at higher concentrations there was a loss in 
activity of both AChE and AAA reaching -80% 
loss at 10 mM DOC. The loss in activity in the su- 
pernatant was not due to decreased solubilization 
as may be seen from the activity values given for 
the 105 000 x g residue in fig. 1. 
Numerous lines of evidence suggested that the 
solubilization at 3 mM DOC was due to an endo- 
genous PI-specific phospholipase C. Thus the 
phospholipase C activity in the basal ganglia ho- 
mogenate with no DOC, with 3 mM and l0 mM 
DOC were 2, 24 and l0 units/0.3 ml, respectively. 
There was only 12-15% solubilization with 3 mM 
DOC if the pH of the medium was 5.0 or 9.2, val- 
ues unfavourable for phospholipase C action [7]. 
Inclusion of 1.2 and 4 mg PI (as competitive inhib- 
itor) with 3 mM DOC at pH 7.4 resulted in 45-  
50%, 65-67% and 80% inhibition of solubilization 
of AChE and AAA. Use of 4 mg PC instead of PI 
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Fig.2. Activation by PI of 10 mM DOC-inactivated 
AChE and AAA. (A) Basal ganglia homogenate was in- 
cubated with 10 mM DOC at 37"C for 30 min and cen- 
trifuged at 105 000xg for 60 min. The supernatant was 
purified by passage through con A-Sepharose as in sec- 
tion 2. (B) AChE and AAA solubilized by S. aureus 
phospholipase C from basal ganglia homogenate was 
treated with l0 mM DOC and purified by con A-  
Sepharose chromatography as in section 2. PI (o), PC 
(=), PE (~) and PS (o) were added at the given amounts 
to 0.15 ml of the purified enzymes, kept for l0 h at 4°C 
with shaking and then assayed for AChE and AAA ac- 
tivity: (---) AAA activity; ( - - )  indicates AChE activity. 
hibition by PC may be due to its ability to alter the 
PC to endogenous PI ratio which is known to af- 
fect the phospholipase C activity [14,15]. 
The endogenous phospholipase C activatable by 
DOC appeared to be a soluble enzyme which 
needed Ca 2 + for activity. If the homogenate was 
first centrifuged at 105 000Xg and the residue 
after washing with 50 mM Hepes/NaOH buffer 
(pH 7.4) subjected to 3 mM DOC treatment, either 
in presence or absence of 1 mM Ca 2+, there was 
no significant solubilization of AChE and AAA 
from the residue. Furthermore, the phospholipase 
C activity was detectable in the 105 000 x g super- 
natant which upon dialysis failed to exhibit the ac- 
tivity unless 1 mM Ca 2+ was included in assay. 
Mixing the 105000×g supernatant with the 
105 000xg residue in the presence of 3 mM DOC 
resulted in 60% solubilization of both AChE and 
AAA. 
3.3. Inactivation of AChE and AAA by 10 mM 
DOC and reactivation by PI 
The solurilized enzymes obtained by bacterial 
phospholipase C or 3 mM DOC treatment after 
purification by con A-Sepharose chromatography 
did not exhibit any activation by different phos- 
pholipids including PI. 
When the bacterial phospholipase C-solubilized 
enzyme was incubated with 10 mM DOC there 
was 80% inactivation of both AChE and AAA sim- 
ilar to the observation made when 10 mM DOC 
alone was used for solubilization. There was no 
such inactivation when 3 mM DOC was used. This 
indicated that DOC at 10 mM caused the inactiva- 
tion of AChE and AAA irrespective of whether the 
enzyme was solubilized by bacterial or endogenous 
phospholipase C.
The inactivated, solubilized enzyme obtained 
either by treatment with 10 mM DOC alone or by 
incubation of the bacterial phospholipase C sol- 
ubilized enzyme with 10 mM DOC, were purified 
by con A-Sepharose chromatography and the 
effect of various phospholipids on the enzyme ac- 
tivities tested (fig.2A,B). It was found that PI alone 
but not PC, PE or PS was able to reactivate AChE 
and AAA up to a maximum of 300% at the highest 
concentration f PI used. This reactivation resulted 
in -60-75% restoration of the activity present in 
the active solubilized enzyme (either with 3 mM 
DOC or by bacterial phospholipase C). 
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3.4. Alka l ine  phosphatase  
This membrane-bound enzyme was also sol- 
ubilized from the basal ganglia to -65% by the S. 
aureus phospholipase C under these conditions. 
However, there was no significant inactivation of 
the alkaline phosphatase by 10 mM or even 
20 mM DOC. 
4. DISCUSSION 
PI-specific phospholipase C has found use as a 
powerful tool for the release of several insoluble 
enzymes uch as alkaline phosphatase, AChE and 
5'-nucleotidase from mammalian membranes 
[5,6,13]. These studies clearly indicated that either 
the bacterial or DOC-activated endogenous PI- 
specific phospholipase C solubilized the basal 
ganglia AChE and AAA. We also observed that 
10 mM DOC inactivated the released AChE and 
AAA and reactivation could be achieved selec- 
tively by PI but not by other phospholipids. This 
inactivation-reactivation phenomenon was ob- 
served specifically for AChE and AAA but not for 
alkaline phosphatase. It is not yet clear whether 
the inactivation by 10 mM DOC is due to its de- 
tergent action or not, but the specific reactivation 
by PI suggested that this inactivation involved cer- 
tain PI residues. The most plausible explanation 
for our observations is the following: 
There are two species of PI involved in the an- 
choring of AChE and AAA to basal ganglia mem- 
brane, one essential for catalytic activity and the 
other non-essential. While 3 mM DOC or S. au- 
reus phospholipase C treatment affect only the 
non-essential PI residues resulting in solubilization 
of enzyme, 10 mM DOC affects the essential PI 
residues needed for catalytic activity. It appears 
that the disposition of PI in the membrane-bound 
enzyme is an essential factor for determining its 
solubilization as well as for protection of its cataly- 
tic activity. The identical behaviour of AChE and 
AAA in the solubilization procedure and reactiva- 
tion by PI also provide additional evidence for the 
identity in the lipid environment of these two en- 
zymes. 
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